Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Dose optimisation for Loss of Response to Vedolizumab- Pharmacokinetics and Immune Mechanisms.
J Crohns Colitis. 2021 Oct 7;15(10):1707-1719. doi: 10.1093/ecco-jcc/jjab067.
J Crohns Colitis. 2021.
PMID: 33837762
Ashkenazi Jewish origin protects against formation of antibodies to infliximab and therapy failure.
Ungar B, Haj-Natour O, Kopylov U, Yavzori M, Fudim E, Picard O, Loebstein R, Lahat A, Maor Y, Avidan B, Lang A, Weiss B, Chowers Y, Eliakim R, Ben-Horin S.
Ungar B, et al. Among authors: haj natour o.
Medicine (Baltimore). 2015 May;94(18):e673. doi: 10.1097/MD.0000000000000673.
Medicine (Baltimore). 2015.
PMID: 25950682
Free PMC article.
Item in Clipboard
Association of Induction Infliximab Levels With Clinical Response in Perianal Crohn's Disease.
Davidov Y, Ungar B, Bar-Yoseph H, Carter D, Haj-Natour O, Yavzori M, Chowers Y, Eliakim R, Ben-Horin S, Kopylov U.
Davidov Y, et al. Among authors: haj natour o.
J Crohns Colitis. 2017 May 1;11(5):549-555. doi: 10.1093/ecco-jcc/jjw182.
J Crohns Colitis. 2017.
PMID: 28453755
Item in Clipboard
Association of Vedolizumab Level, Anti-Drug Antibodies, and α4β7 Occupancy With Response in Patients With Inflammatory Bowel Diseases.
Ungar B, Kopylov U, Yavzori M, Fudim E, Picard O, Lahat A, Coscas D, Waterman M, Haj-Natour O, Orbach-Zingboim N, Mao R, Chen M, Chowers Y, Eliakim R, Ben-Horin S.
Ungar B, et al. Among authors: haj natour o.
Clin Gastroenterol Hepatol. 2018 May;16(5):697-705.e7. doi: 10.1016/j.cgh.2017.11.050. Epub 2017 Dec 7.
Clin Gastroenterol Hepatol. 2018.
PMID: 29223444
Item in Clipboard
Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional Study.
Veisman I, Barzilay O, Bruckmayer L, Haj-Natour O, Kopylov U, Eliakim R, Ben-Horin S, Ungar B.
Veisman I, et al. Among authors: haj natour o.
J Clin Med. 2021 Sep 20;10(18):4265. doi: 10.3390/jcm10184265.
J Clin Med. 2021.
PMID: 34575376
Free PMC article.
Item in Clipboard
Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease - a retrospective study.
Livne-Margolin M, Ling D, Attia-Konyo S, Abitbol CM, Haj-Natour O, Ungar B, Ben-Horin S, Kopylov U.
Livne-Margolin M, et al. Among authors: haj natour o.
Dig Liver Dis. 2023 Feb;55(2):223-229. doi: 10.1016/j.dld.2022.09.009. Epub 2022 Oct 11.
Dig Liver Dis. 2023.
PMID: 36241535
Item in Clipboard
Patency Capsule: A Novel Independent Predictor for Long-Term Outcomes Among Patients With Quiescent Crohn's Disease.
Ukashi O, Kopylov U, Ungar B, Haj-Natour O, Selinger L, Neuman S, Yanai H, Dotan I, Yablecovitch D, Lahat A, Eliakim R, Ben-Horin S; Israeli IBD Research Nucleus (IIRN).
Ukashi O, et al. Among authors: haj natour o.
Am J Gastroenterol. 2023 Jun 1;118(6):1019-1027. doi: 10.14309/ajg.0000000000002118. Epub 2022 Dec 23.
Am J Gastroenterol. 2023.
PMID: 36563317
Item in Clipboard
Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II Study.
Harnik S, Abitbol CM, Haj Natour O, Yavzori M, Fudim E, Picard O, Naftali T, Broide E, Hirsch A, Selinger L, Shachar E, Yablecovitch D, Albshesh A, Coscas D, Kopylov U, Eliakim R, Ben-Horin S, Ungar B.
Harnik S, et al. Among authors: haj natour o.
J Crohns Colitis. 2024 Mar 1;18(3):341-348. doi: 10.1093/ecco-jcc/jjad156.
J Crohns Colitis. 2024.
PMID: 37691574
Item in Clipboard
Cite
Cite